Clinical trial
An Early Feasibility Study of the Safety and Efficacy of the Nucleus 24 Auditory Brainstem Implant in Children With Cochlear or Cochlear Nerve Disorders Not Resulting From Neurofibromatosis Type II
NCT01904448 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Feasibility Study of the Safety and Efficacy of the Nucleus 24 Auditory Brainstem Implant in Children With Cochlear or Cochlear Nerve Disorders Not Resulting From Neurofibromatosis Type II
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- October 1, 2017
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acquired cochlear nerve deficiency, cochlear aplasia, cochlear malformation, developmental cochlear nerve deficiency, post-meningitis cochlear ossification